We are live on ! Find out more
NVO

Novo Nordisk

548 hedge funds and large institutions have $11.7B invested in Novo Nordisk in 2015 Q4 according to their latest regulatory filings, with 64 funds opening new positions, 192 increasing their positions, 192 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

577% more call options, than puts

Call options by funds: $34.8M | Put options by funds: $5.14M

88% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 34

19% more funds holding in top 10

Funds holding in top 10: 3238 (+6)

6% more capital invested

Capital invested by funds: $11B → $11.7B (+$691M)

4% more funds holding

Funds holding: 525548 (+23)

0% more repeat investments, than reductions

Existing positions increased: 192 | Existing positions reduced: 192

0.11% less ownership

Funds ownership: 19.75%19.64% (-0.11%)

Holders
548
Holders Change
+23
Holders Change %
+4.38%
% of All Funds
14.38%
Holding in Top 10
38
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+18.75%
% of All Funds
1%
New
64
Increased
192
Reduced
192
Closed
34
Calls
$34.8M
Puts
$5.14M
Net Calls
+$29.6M
Net Calls Change
+$44.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Jennison Associates
1
Jennison Associates
New York
$869M -$178M -6,415,622 -18%
Bank of America
2
Bank of America
North Carolina
$850M -$11.9M -428,320 -1%
Renaissance Technologies
3
Renaissance Technologies
New York
$749M -$15.1M -544,400 -2%
Fisher Asset Management
4
Fisher Asset Management
Washington
$665M -$11.3M -409,710 -2%
JSP
5
Jackson Square Partners
California
$600M +$14M +504,836 +3%
Ameriprise
6
Ameriprise
Minnesota
$599M +$17.4M +627,338 +3%
Loomis, Sayles & Company
7
Loomis, Sayles & Company
Massachusetts
$595M +$25.3M +914,846 +5%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$544M +$5.34M +193,066 +1%
Arrowstreet Capital
9
Arrowstreet Capital
Massachusetts
$458M +$56.2M +2,028,866 +15%
WCM Investment Management
10
WCM Investment Management
California
$455M +$77.3M +2,793,298 +22%
F
11
Folketrygdfondet
Norway
$403M +$10.3M +372,258 +3%
Fayez Sarofim & Co
12
Fayez Sarofim & Co
Texas
$350M -$13.2M -477,628 -4%
State Farm Mutual Automobile Insurance
13
State Farm Mutual Automobile Insurance
Illinois
$259M +$33M +1,191,688 +15%
Macquarie Group
14
Macquarie Group
Australia
$224M -$3.79M -136,802 -2%
EHC
15
Everett Harris & Co
California
$179M +$67.8K +2,450 +0%
Capital International Investors
16
Capital International Investors
California
$165M
DAC
17
Dividend Assets Capital
South Carolina
$160M -$3.21K -116 -0%
Northern Trust
18
Northern Trust
Illinois
$155M +$7.68M +277,438 +5%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$136M -$19.9M -719,148 -13%
SBAM
20
Santa Barbara Asset Management
California
$114M +$1.53M +55,232 +1%
HL
21
Harding Loevner
New Jersey
$103M -$59.1M -2,135,324 -37%
Lazard Asset Management
22
Lazard Asset Management
New York
$102M -$21.6M -781,748 -18%
EVM
23
Eaton Vance Management
Massachusetts
$101M -$614K -22,170 -0.6%
LWCFA
24
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$101M +$1.75M +63,080 +2%
Wells Fargo
25
Wells Fargo
California
$101M -$4.08M -147,536 -4%

NVO Hedge Fund Activity: Q4 2015 in Review

548 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q4 2015, worth a combined $11.7B — up 6.3% from $11B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new NVO positions and 34 closed out — a net gain of 30 holders — while 192 added to existing stakes and 192 trimmed.

The largest buyer was WCM Investment Management, adding an estimated $77.3M. The largest seller was Jennison Associates, cutting an estimated $178M.

  • 548 institutional investors held Novo Nordisk (NVO) as of Q4 2015, up from 525 in Q3 2015.
  • Funds reported $11.7B of Novo Nordisk stock for Q4 2015, up 6.3% quarter-over-quarter.
  • 64 funds opened new Novo Nordisk positions in Q4 2015 and 34 closed out, a net change of +30 holders.
  • The largest Novo Nordisk buyer in Q4 2015 was WCM Investment Management, an estimated $77.3M added.
  • The largest Novo Nordisk seller in Q4 2015 was Jennison Associates, an estimated $178M sold.

Based on aggregated 13F filings for Q4 2015.